Amyris, Inc., a company operating in the development and production of sustainable ingredients for the health & wellness, clean beauty and flavors & fragrances markets, announced the appointment of Oreste Fieschi as president of sweeteners & ingredients, to lead the commercial growth of its sweetener business and the implementation of its strategy to build capability across the entire ingredients portfolio.
Fieschi has a successful track record in commercial leadership roles in the food and beverage and natural ingredients sectors, along with deep expertise in global markets. This new position is driven by growth across Amyris’s businesses and within the expanding market for the company’s new, sugarcane-derived zero calorie sweetener.
Most recently, he led global sales and marketing as the Chief Commercial Officer for Naturex, a leader in natural ingredients recently bought by Givaudan. He has over 20 years’ experience in senior commercial roles in diverse markets including chemicals, personal care, and food & beverage, including six years leading the sales growth strategy for Tate & Lyle Latin America. Prior to that, he held key commercial and business development roles with such companies as IFF, a leading developer and manufacturer of flavors and fragrances. Fieschi holds a master’s degree in Business Administration from the Business School São Paulo, BSP (in partnership with Toronto University), and several other education certifications in finance and accounting, marketing, and chemical engineering.
“We welcome Oreste to Amyris at an inflection point when our businesses are experiencing solid, recurring revenue growth,” said John Melo, Amyris president & CEO. “His proven experience as a successful leader in the markets we are growing, gives us a significant advantage toward maximizing the real opportunities ahead of us for revenue growth through key partnerships for our No Compromise™ ingredients.”
Based in São Paulo and fluent in English, Portuguese and Spanish, Fieschi will leverage his deep expertise globally to execute on Amyris's accelerated demand for the sweetener business.
